Mycobacterium Chelonae Guidelines

Updated: Jun 07, 2022
  • Author: Mary B Ford, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


The following are the 3 main guidelines published to help with diagnosis and management of NTM infections:

2007 ATS/IDSA Statement on Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

This statement addresses the most common clinical manifestations of and treatment for commonly accepted clinically relevant NTM species. It also provides a discussion on basic epidemiology, pathogenesis, and laboratory procedures associated with NTM. This paper specifically addresses M chelonae [8]

2017 British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

This guideline addresses the management of NTM-PD caused by the most commonly identified NTM, which does not include M chelonae. [45]

2020 Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

This guideline focuses primarily on pulmonary disease in adults caused by NTM most commonly identified as pulmonary pathogens. Guidance on M chelonae is not included in this document. [2]